HOME › DRUGS › ORPHENADRINE CITRATE
ACTIVE SUBSTANCE / INN

ORPHENADRINE CITRATE

Brand name(s): NORGESIC, ORPHENGESIC, NORGESIC FORTE, NORFLEX, ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE, ORPHENADRINE CITRATE, ORPHENGESIC FORTE, INVAGESIC, INVAGESIC FORTE
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA074654
NDA013055
ACTIVE SUBSTANCE
Orphenadrine Citrate
REGULATORS
FDA
SPONSORS / MAH
WATSON LABS, SANDOZ, PAI HOLDINGS PHARM
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ORPHENADRINE CITRATEANDA084303WATSON LABSDiscontinued
ORPHENADRINE CITRATEANDA090585SAGENT PHARMSPrescription
INVAGESICANDA074817CHARTWELL RXDiscontinued
INVAGESIC FORTEANDA074817CHARTWELL RXDiscontinued
NORFLEXNDA013055PAI HOLDINGS PHARMDiscontinued
ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINEANDA074654SANDOZDiscontinued
NORGESIC FORTENDA013416BAUSCHDiscontinued
NORGESICNDA013416BAUSCHDiscontinued
ORPHENGESICANDA075141GALT PHARMSPrescription
ORPHENGESIC FORTEANDA075141GALT PHARMSPrescription

FULL INTELLIGENCE ON ORPHENADRINE CITRATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →